(firstQuint)An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion.

 The objective is to show non-inferiority in adhesion of BTDS patch 40 mu g/h compared to BTDS patch 20 mu g/h.

 Safety and tolerability of both patches will also be assessed.

.

 An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion@highlight

The purpose of this study is to assess the adhesion of BTDS patch 40 mu g/h.

